Biotech News

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

Hyperfine (HYPR)HyperfineEarnings

GUILFORD, Conn. --(BUSINESS WIRE)--Apr. 28, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial

Open original release

Related news

Hyperfine

Hyperfine is a medical device company focused on portable MRI systems and point-of-care imaging. Its business is centered on making advanced imaging more accessible outside traditional radiology settings.

Recent company news

Stock data

Close
0.96 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States